Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Bodycote maintains FY outlook amid strong growth in core business
(Sharecast News) - Heat treatment specialist Bodycote said on Wednesday that trading over the first four months of the year was in line with expectations, with the group maintaining its full‑year outlook as strong growth in its core business offset the impact of ongoing plant exits. Bodycote said group revenues were up 1.9% at constant currency, while core revenues rose 9% against a soft comparator, with the company highlighting continued strong momentum in aerospace and defence and accelerating demand in industrial gas turbines.
Industrial markets were flat overall, with solid European activity offset by weaker US volumes, while automotive revenue declined in line with lower global light‑vehicle production.
Bodycote's specialist technologies unit led divisional performance, with 16.5% organic growth, while its precision heat treatment arm reported organic growth of 4.8%. Bodycote said the stronger showing in its specialist technologies division reflected both favourable end‑market exposure and the unwinding of prior‑year headwinds in oil & gas and medical.
The FTSE 250-listed group also highlighted that 21 non‑core sites have now been exited, with three more ceasing operations, and revenue transfers and costs tracking to plan.
Looking ahead, Bodycote reiterated expectations for core organic revenue growth and improved margins in FY26, though it cautioned that growth would moderate through the year as comparators toughen and geopolitical uncertainty remains elevated.
As of 1110 BST, Bodycote shares were up 0.72% at 842.50p.
Reporting by Iain Gilbert at Sharecast.com
See latest RNS at Investegate
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.